New Mayo Clinic Technology Helps Solve the Unsolvable in Rare Disease Diagnoses
Mayo Clinic
While manual reanalysis takes weeks, the new technology took from 10 seconds to 1.5 hours to reanalyze each unresolved case
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
Easy-to-implement technology reduces the per-reaction cost of target capture by two to three orders of magnitude as compared to commercial solutions